Cabot (CBT) Set to Release Earnings on Monday

Cabot (NYSE:CBT) is anticipated to announce its Q4 2026 results after the market closes on Monday, November 2nd. Analysts expect the company to post earnings of $1.55 per share and revenue of $927.29 million for the quarter. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Parties may visit the company’s upcoming Q4 2026 earnings overview page for the latest details on the call scheduled for Tuesday, November 3, 2026 at 8:00 AM ET.

Cabot (NYSE:CBT) last released its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.66 by $0.01. The company had revenue of $982.00 million during the quarter, compared to the consensus estimate of $943.16 million. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The company’s revenue was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.90 EPS. On average, analysts expect Cabot to post $6.35 EPS for the current fiscal year and $7.08 EPS for the next fiscal year.

Cabot Trading Up 1.0%

Shares of NYSE:CBT opened at $74.57 on Friday. The firm has a fifty day moving average of $77.98 and a two-hundred day moving average of $79.50. The firm has a market capitalization of $3.85 billion, a P/E ratio of 21.01, a price-to-earnings-growth ratio of 8.76 and a beta of 0.83. Cabot has a 12-month low of $58.33 and a 12-month high of $94.53. The company has a quick ratio of 0.97, a current ratio of 1.47 and a debt-to-equity ratio of 0.48.

Analysts Set New Price Targets

CBT has been the subject of several recent research reports. UBS Group cut their price objective on Cabot from $92.00 to $86.00 and set a “neutral” rating for the company in a report on Monday, October 5th. Truist Financial set a $100.00 target price on Cabot in a research note on Wednesday, August 5th. Wall Street Zen raised Cabot from a “hold” rating to a “buy” rating in a research report on Sunday, October 11th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a research report on Friday, August 21st. Finally, JPMorgan Chase & Co. raised their price target on Cabot from $70.00 to $78.00 and gave the stock an “underweight” rating in a research note on Friday, August 7th. Two analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $87.80.

Insiders Place Their Bets

In other news, CEO Sean Keohane sold 134,895 shares of Cabot stock in a transaction that occurred on Friday, August 28th. The shares were sold at an average price of $85.00, for a total value of $11,466,075.00. Following the transaction, the chief executive officer owned 404,134 shares of the company’s stock, valued at $34,351,390. This trade represents a 25.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In the last three months, insiders sold 229,597 shares of company stock valued at $19,646,746. 3.08% of the stock is currently owned by insiders.

Cabot Company Profile

Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company develops and manufactures materials used to improve the performance, durability, conductivity, color and purity of products across a range of industries.

Cabot’s products include carbon black used in tires, rubber goods, coatings, plastics and printing inks; specialty carbons and conductive materials for batteries and other applications; and specialty compounds and masterbatches.